ES2477549T3 - Diagnóstico del cáncer según la concentración de anticuerpos contra Globo H y sus fragmentos - Google Patents

Diagnóstico del cáncer según la concentración de anticuerpos contra Globo H y sus fragmentos Download PDF

Info

Publication number
ES2477549T3
ES2477549T3 ES09798419.9T ES09798419T ES2477549T3 ES 2477549 T3 ES2477549 T3 ES 2477549T3 ES 09798419 T ES09798419 T ES 09798419T ES 2477549 T3 ES2477549 T3 ES 2477549T3
Authority
ES
Spain
Prior art keywords
cancer
antibodies
sample
globo
globe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09798419.9T
Other languages
English (en)
Spanish (es)
Inventor
Chi-Huey Wong
Chung-Yi Wu
Cheng-Chi Wang
Alice L. Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Academia Sinica
Original Assignee
Academia Sinica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academia Sinica filed Critical Academia Sinica
Application granted granted Critical
Publication of ES2477549T3 publication Critical patent/ES2477549T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES09798419.9T 2008-06-16 2009-06-16 Diagnóstico del cáncer según la concentración de anticuerpos contra Globo H y sus fragmentos Active ES2477549T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6197408P 2008-06-16 2008-06-16
US61974P 2008-06-16
PCT/US2009/047532 WO2010008736A2 (en) 2008-06-16 2009-06-16 Cancer diagnosis based on levels of antibodies against globo h and its fragments

Publications (1)

Publication Number Publication Date
ES2477549T3 true ES2477549T3 (es) 2014-07-17

Family

ID=41431641

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09798419.9T Active ES2477549T3 (es) 2008-06-16 2009-06-16 Diagnóstico del cáncer según la concentración de anticuerpos contra Globo H y sus fragmentos

Country Status (11)

Country Link
US (1) US8158367B2 (https=)
EP (1) EP2307887B1 (https=)
JP (1) JP5216139B2 (https=)
KR (1) KR101324109B1 (https=)
CN (1) CN102066940B (https=)
AU (1) AU2009271411B2 (https=)
CA (1) CA2728574C (https=)
ES (1) ES2477549T3 (https=)
MX (1) MX2010013931A (https=)
NZ (1) NZ590064A (https=)
WO (1) WO2010008736A2 (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
ES2442024T3 (es) 2008-07-15 2014-02-07 Academia Sinica Matrices de glucano sobre portaobjetos de vidrio revestidos con aluminio de tipo PTFE y métodos relacionados
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
CA2782472C (en) 2009-12-15 2019-04-16 The Hospital For Sick Children Method of treating scars and beta-catenin-mediated disorders
US10338069B2 (en) 2010-04-12 2019-07-02 Academia Sinica Glycan arrays for high throughput screening of viruses
WO2013010003A1 (en) 2011-07-12 2013-01-17 University Of Medicine And Dentistry Of New Jersey Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
WO2014018903A1 (en) * 2012-07-27 2014-01-30 Rowan University Autoantibody profiles in early detection and diagnosis of cancer
WO2014031498A1 (en) 2012-08-18 2014-02-27 Academia Sinica Cell-permeable probes for identification and imaging of sialidases
EP3013365B1 (en) * 2013-06-26 2019-06-05 Academia Sinica Rm2 antigens and use thereof
EP3013347B1 (en) 2013-06-27 2019-12-11 Academia Sinica Glycan conjugates and use thereof
JP6486368B2 (ja) 2013-09-06 2019-03-20 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 改変されたグリコシル基を含む糖脂質を用いたヒトｉＮＫＴ細胞の活性化
CN104698183A (zh) * 2013-12-04 2015-06-10 苏州中赢医疗科技有限公司 一种肝癌肿瘤标志物、其抗体及应用
AU2015206370A1 (en) 2014-01-16 2016-07-07 Academia Sinica Compositions and methods for treatment and detection of cancers
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
JP2017518958A (ja) 2014-03-19 2017-07-13 マッカイ メディカル ファウンデイション ザ プレスビテリアン チャーチ イン タイワン マッカイ メモリアル ホスピタルＭａｃｋａｙ Ｍｅｄｉｃａｌ Ｆｏｕｎｄａｔｉｏｎ Ｔｈｅ Ｐｒｅｓｂｙｔｅｒｉａｎ Ｃｈｕｒｃｈ Ｉｎ Ｔａｉｗａｎ Ｍａｃｋａｙ Ｍｅｍｏｒｉａｌ Ｈｏｓｐｉｔａｌ 免疫原性グリコペプチドに対する抗体、それを含む組成物、及びそれらの使用
CN106415244B (zh) 2014-03-27 2020-04-24 中央研究院 反应性标记化合物及其用途
CA2941029C (en) 2014-04-10 2021-02-16 Obi Pharma Inc. Antibodies, pharmaceutical compositions and uses thereof
CN106661099A (zh) 2014-05-27 2017-05-10 中央研究院 抗her2醣抗体及其用途
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
CA2950415A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-cd20 glycoantibodies and uses thereof
JP7093612B2 (ja) 2014-05-27 2022-06-30 アカデミア シニカ Ｂａｃｔｅｒｏｉｄｅｓ由来のフコシダーゼおよびそれを使用する方法
WO2015184001A1 (en) 2014-05-28 2015-12-03 Academia Sinica Anti-tnf-alpha glycoantibodies and uses thereof
TWI745275B (zh) 2014-09-08 2021-11-11 中央研究院 使用醣脂激活人類ｉＮＫＴ細胞
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
JP6779887B2 (ja) 2015-01-24 2020-11-04 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ 新規なグリカンコンジュゲートおよびその使用方法
AU2016209056B2 (en) 2015-01-24 2021-01-28 Academia Sinica Cancer markers and methods of use thereof
WO2016123593A1 (en) 2015-01-30 2016-08-04 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
WO2017018049A1 (ja) * 2015-07-30 2017-02-02 京セラ株式会社 測定方法、および測定装置
US10935544B2 (en) * 2015-09-04 2021-03-02 Obi Pharma, Inc. Glycan arrays and method of use
EP3426693A4 (en) 2016-03-08 2019-11-13 Academia Sinica PROCESS FOR MODULAR SYNTHESIS OF N-GLYCANES AND ARRANGEMENTS THEREOF
US11643456B2 (en) * 2016-07-29 2023-05-09 Obi Pharma, Inc. Human antibodies, pharmaceutical compositions and methods
CA3034057A1 (en) 2016-08-22 2018-03-01 CHO Pharma Inc. Antibodies, binding fragments, and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998046246A1 (en) 1997-04-16 1998-10-22 Sloan-Kettering Institute For Cancer Research α-O-LINKED GLYCOCONJUGATES WITH CLUSTERED (2,6)-ST EPITOPES, METHODS OF PREPARATION AND USES THEREOF
CN1235831A (zh) * 1999-03-02 1999-11-24 第一军医大学珠江医院 含红细胞糖苷脂的药物组合物及其应用
WO2001065261A1 (en) * 2000-02-29 2001-09-07 Sloan-Kettering Institute For Cancer Research Affinity matrix bearing tumor-associated antigens
WO2006068758A2 (en) * 2004-11-19 2006-06-29 The Scripps Research Institute Detection, prevention and treatment of breast cancer
US20060269979A1 (en) * 2005-04-26 2006-11-30 Dwek Raymond A High throughput glycan analysis for diagnosing and monitoring rheumatoid arthritis and other autoimmune diseases
US20090162405A1 (en) * 2006-12-14 2009-06-25 Yong Qian Proteinase-engineered cancer vaccine induces immune responses to prevent cancer and to systemically kill cancer cells
AU2009268937A1 (en) * 2008-06-16 2010-01-14 Aj Park Compositions for inducing immune responses specific to Globo H and SSEA3 and uses thereof in cancer treatment

Also Published As

Publication number Publication date
US8158367B2 (en) 2012-04-17
JP5216139B2 (ja) 2013-06-19
JP2011524537A (ja) 2011-09-01
EP2307887B1 (en) 2014-05-07
KR101324109B1 (ko) 2013-10-31
CN102066940B (zh) 2015-05-13
MX2010013931A (es) 2011-06-01
AU2009271411B2 (en) 2013-02-07
CN102066940A (zh) 2011-05-18
US20090317837A1 (en) 2009-12-24
WO2010008736A2 (en) 2010-01-21
EP2307887A2 (en) 2011-04-13
AU2009271411A1 (en) 2010-01-21
KR20110033919A (ko) 2011-04-01
HK1153273A1 (en) 2012-03-23
CA2728574A1 (en) 2010-01-21
CA2728574C (en) 2020-10-20
EP2307887A4 (en) 2011-09-21
WO2010008736A3 (en) 2010-03-11
NZ590064A (en) 2012-05-25

Similar Documents

Publication Publication Date Title
ES2477549T3 (es) Diagnóstico del cáncer según la concentración de anticuerpos contra Globo H y sus fragmentos
Oyelaran et al. Profiling human serum antibodies with a carbohydrate antigen microarray
Oyelaran et al. Microarrays with varying carbohydrate density reveal distinct subpopulations of serum antibodies
JPWO2009091023A1 (ja) 腎癌の診断又は検出のための組成物及び方法
JPWO2014185387A1 (ja) 免疫療法の臨床効果の予測法
JP2011502244A (ja) Ｅｄｔａ耐性ｓ１００ａ１２複合体（ｅｒａｃ）
CN112513288B (zh) 细菌性阴道病诊断
KR101203399B1 (ko) 신속 면역크로마토그라피법을 이용한 신종 인플루엔자 진단 키트
Schmidhuber et al. A Novel C-type lectin receptor-targeted α-synuclein-based parkinson vaccine induces potent immune responses and therapeutic efficacy in mice
WO2008001944A1 (en) Reagent for detection of autoantibody and kit for diagnosis of autoimmune disease
Smeenk Methodological update detection of antibodies to dsDNA: current insights into its relevance
WO2001065261A1 (en) Affinity matrix bearing tumor-associated antigens
Larsen et al. Raising an antibody specific to breast cancer subpopulations using phage display on tissue sections
CN103555668B (zh) 杂交瘤细胞株及其产生的抗Wnt5a单克隆抗体与应用
CN105367626A (zh) 用于检测宫颈癌的多肽、检测器件和检测试剂盒
JPWO2018143336A1 (ja) 膵臓癌の検査方法
HK1153273B (en) Cancer diagnosis based on levels of antibodies against globo h and its fragments
CN106892967A (zh) 用于检测宫颈癌的多肽、检测器件和检测试剂盒
WO2021187173A1 (ja) 消化管間質腫瘍を検出する方法および検出試薬
CN105384795A (zh) 用于检测宫颈癌的多肽、检测器件和检测试剂盒
CN102952190A (zh) 一个微泡膜蛋白及其应用